Discovery of a potent, selective, and orally available class I phosphatidylinositol 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) kinase inhibitor (GDC-0980) …
DP Sutherlin, L Bao, M Berry…
文献索引:Journal of Medicinal Chemistry, , vol. 54, # 21 p. 7579 - 7587